Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma

被引：0
|
作者：
Desai, Mauli [1 ]
Haines, Adam [2 ]
Oppenheimer, John J. [3 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Allergy & Immunol, 111 East 210th St, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat, Div Allergy & Immunol, 111 East 210th St, Bronx, NY 10467 USA
[3] UMDNJ Rutgers, Dept Med, Div Allergy& Immunol, 110 Bergen St Suite 1, Newark, NJ 07103 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2024年 / 44卷 / 04期
关键词：
Severe asthma; Real-world studies; Omalizumab; Mepolizumab; Reslizumab; Benralizumab; Dupilumab; Tezepelumab; SEVERE EOSINOPHILIC ASTHMA; ALLERGIC-ASTHMA; TEZEPELUMAB-EKKO; OMALIZUMAB; THERAPY; ADULTS; MEPOLIZUMAB; EXACERBATIONS; ADOLESCENTS; DUPILUMAB;
D O I：
10.1016/j.iac.2024.07.007
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：737 / 750
页数：14
相关论文
共 50 条
  • [41] Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasis
    Gooderham, Melinda J.
    Lynde, Charles
    Turchin, Irina
    Avadisian, Miriam
    Labelle, Melanie
    Papp, Kim A.
    JOURNAL OF DERMATOLOGY, 2022, 49 (01) : 95 - 105
  • [42] Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE)
    Kanniess, Frank
    Tamasi, Lilla
    Mroz, Robert R.
    Bakakos, Petros
    Tubis, Susanne
    Plat, Gustavo Resler
    Shavit, Anat
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [43] Real-world effectiveness and safety of omalizumab in patients with uncontrolled severe allergic asthma from the Czech Republic
    Kirchnerova, Olga Ruzickova
    Valena, Tomas
    Novosad, Jakub
    Terl, Milan
    Bystron, J.
    Chlumsky, J.
    Kindlova, D.
    Klosova, J.
    Krcmova, I
    Parakova, Z.
    Pohunek, P.
    Popelkova, P.
    Sedlak, V
    Vanik, P.
    Vernerova, E.
    Zatloukal, J.
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2019, 36 (01): : 34 - 43
  • [44] Difficult-To-Treat and Severe Asthma: Can Real-World Studies On Effectiveness of Biological Treatments Change the Lives of Patients?
    Pelaia, Corrado
    Giacalone, Antonio
    Ippolito, Gianluca
    Pastore, Daniela
    Maglio, Angelantonio
    Piazzetta, Giovanna Lucia
    Lobello, Nadia
    Lombardo, Nicola
    Vatrella, Alessandro
    Pelaia, Girolamo
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2024, 15 : 45 - 51
  • [45] Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis
    Lopes, Sara R.
    Martins, Claudio
    Teixeira, Madalena
    Tomas, David
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (34) : 3929 - 3931
  • [46] Effectiveness and Safety Studies of Omalizumab in Children and Adolescents With Moderate-To-Severe Asthma
    Cheng, Lu
    Yang, Tianrui
    Ma, Xiang
    Han, Yuling
    Wang, Yongtai
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (02) : 370 - 382
  • [47] Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center
    Jung, Seung-Won
    Lim, Sung Ha
    Jeon, Jae Joon
    Heo, Yeon-Woo
    Choi, Mi Soo
    Hong, Seung-Phil
    BIOMEDICINES, 2022, 10 (05)
  • [48] Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis
    Tomomatsu, Katsuyoshi
    Yasuba, Hirotaka
    Ishiguro, Takashi
    Imokawa, Shiro
    Hara, Johsuke
    Soeda, Seiko
    Harada, Norihiro
    Tsurikisawa, Naomi
    Oda, Naohiro
    Katoh, Shigeki
    Numata, Takanori
    Sugino, Yasuteru
    Yamada, Mitsuhiro
    Kamimura, Mitsuhiro
    Terashima, Takeshi
    Okada, Naoki
    Tanaka, Jun
    Oguma, Tsuyoshi
    Asano, Koichiro
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [49] Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma
    Menigoz, C.
    Dirou, S.
    Chambellan, A.
    Hassoun, D.
    Moui, A.
    Magnan, A.
    Blanc, F. X.
    JOURNAL OF ASTHMA, 2023, 60 (06) : 1162 - 1170
  • [50] Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma
    Massanari, Marc
    Kianifard, Farid
    Zeldin, Robert K.
    Geba, Gregory P.
    ALLERGY AND ASTHMA PROCEEDINGS, 2009, 30 (05) : 534 - 539
12345